Valerie Kiers, NP
Valerie Kiers, NP
Contact Information
55 Fruit Street
Yawkey Building, Suite 3E
Boston, MA
02114
Children's Orthopaedics617-726-8523: 617-726-8510
About Valerie Kiers, NP
Valerie believes one of the most rewarding aspects of her job is seeing young children get back to the sports and activities they enjoy most. Val also believes in the importance of educating the pediatric population about maintaining a healthy and active lifestyle.
Valerie graduated from the Massachusetts General Hospital Institute of Health Professions in 2019, with her Masters of Science in Nursing and became a certified Pediatric Nurse Practitioner. She worked in the Children's Orthopaedic Service from 2019-2023. From 2023 - early 2025, she was a Pediatric Hospitalist at Hasbro Children’s Hospital. She returned to Mass General's Children's Orthopaedic Service in April 2025. She is originally from West Warwick, RI.
Treats:
- Pediatrics
Languages:
- English
Locations
Mass General - Boston
55 Fruit Street
Yawkey Center for Outpatient Care, Suite 3E
Boston, MA 02114
Children's Orthopaedics: 617-726-8523
Medical Education
- BS in Biology & Health Sciences, Emmanuel College
- NP, Massachusetts General Hospital Institute of Health Professions
Research & Publications
Publications:
- Hanna P, Kiers V, Kim S. (2023). Knotless and tailless subarticular skin closure using monofilament suture may reduce the risk for surgical site infection. American Academic of Orthopedic Surgeons.
- Kim S, Kiers V, Medina G. (2023). Pediatric maisonneuve and tillaux fractures with lateral ankle dislocation “logsplitter” injury: A case report. Journal of Bone and Joint Surgery.
- Paschos NK, Kiers V, McGauley C, Brodeur J, Grottkau B. (2023) Pediatric patients with first-time patella dislocation. A prospective cohort comparing non-operative and operative treatment. International Society of Arthroscopy, Knee Surgery and Orthopedic Sports Medicine
- Nakagawa H, Sido JM, Reyes EE, Kiers V, Cantor H, Kim HJ (2016). Instability of helios-deficient tregs is associated with conversion to a T-effector phenotype and enhanced antitumor immunity. Proceedings of the National Academy of Science, vol. 113(22). Doi: 10.1073/pnas.1604765113.